Marker Therapeutics (MRKR) Asset Utilization Ratio (2016 - 2025)
Historic Asset Utilization Ratio for Marker Therapeutics (MRKR) over the last 10 years, with Q3 2025 value amounting to 0.09.
- Marker Therapeutics' Asset Utilization Ratio fell 11685.39% to 0.09 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.09, marking a year-over-year decrease of 11685.39%. This contributed to the annual value of 0.01 for FY2024, which is 9204.68% down from last year.
- According to the latest figures from Q3 2025, Marker Therapeutics' Asset Utilization Ratio is 0.09, which was down 11685.39% from 0.06 recorded in Q2 2025.
- In the past 5 years, Marker Therapeutics' Asset Utilization Ratio registered a high of 0.55 during Q3 2024, and its lowest value of 0.09 during Q3 2025.
- Over the past 5 years, Marker Therapeutics' median Asset Utilization Ratio value was 0.06 (recorded in 2024), while the average stood at 0.11.
- As far as peak fluctuations go, Marker Therapeutics' Asset Utilization Ratio skyrocketed by 1342702.16% in 2022, and later plummeted by 11785.16% in 2025.
- Marker Therapeutics' Asset Utilization Ratio (Quarter) stood at 0.0 in 2021, then surged by 21243.64% to 0.09 in 2022, then surged by 168.74% to 0.25 in 2023, then plummeted by 74.96% to 0.06 in 2024, then tumbled by 248.46% to 0.09 in 2025.
- Its last three reported values are 0.09 in Q3 2025, 0.06 for Q2 2025, and 0.01 during Q1 2025.